157 related articles for article (PubMed ID: 14648025)
1. Presentation assessment of minor histocompatibility antigens by predictive proteasomal cleavage analysis.
Khattab B; Eiz-Vesper B; Ganser A; Hertenstein B; Blasczyk R
Ann Hematol; 2004 Feb; 83(2):107-13. PubMed ID: 14648025
[TBL] [Abstract][Full Text] [Related]
2. An algorithm for the prediction of proteasomal cleavages.
Kuttler C; Nussbaum AK; Dick TP; Rammensee HG; Schild H; Hadeler KP
J Mol Biol; 2000 May; 298(3):417-29. PubMed ID: 10772860
[TBL] [Abstract][Full Text] [Related]
3. Sequence signals for generation of antigenic peptides by the proteasome: implications for proteasomal cleavage mechanism.
Altuvia Y; Margalit H
J Mol Biol; 2000 Jan; 295(4):879-90. PubMed ID: 10656797
[TBL] [Abstract][Full Text] [Related]
4. Post-proteasomal antigen processing for major histocompatibility complex class I presentation.
Rock KL; York IA; Goldberg AL
Nat Immunol; 2004 Jul; 5(7):670-7. PubMed ID: 15224092
[TBL] [Abstract][Full Text] [Related]
5. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
Mo XY; Cascio P; Lemerise K; Goldberg AL; Rock K
J Immunol; 1999 Dec; 163(11):5851-9. PubMed ID: 10570269
[TBL] [Abstract][Full Text] [Related]
6. Bi-directional allelic recognition of the human minor histocompatibility antigen HB-1 by cytotoxic T lymphocytes.
Dolstra H; de Rijke B; Fredrix H; Balas A; Maas F; Scherpen F; Aviles MJ; Vicario JL; Beekman NJ; Ossendorp F; de Witte TM; van de Wiel-van Kemenade E
Eur J Immunol; 2002 Oct; 32(10):2748-58. PubMed ID: 12355426
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus.
Mommaas B; Kamp J; Drijfhout JW; Beekman N; Ossendorp F; Van Veelen P; Den Haan J; Goulmy E; Mutis T
J Immunol; 2002 Sep; 169(6):3131-6. PubMed ID: 12218130
[TBL] [Abstract][Full Text] [Related]
8. SiPep: a system for the prediction of tissue-specific minor histocompatibility antigens.
Halling-Brown M; Quartey-Papafio R; Travers PJ; Moss DS
Int J Immunogenet; 2006 Aug; 33(4):289-95. PubMed ID: 16893394
[TBL] [Abstract][Full Text] [Related]
9. MAPPP: MHC class I antigenic peptide processing prediction.
Hakenberg J; Nussbaum AK; Schild H; Rammensee HG; Kuttler C; Holzhütter HG; Kloetzel PM; Kaufmann SH; Mollenkopf HJ
Appl Bioinformatics; 2003; 2(3):155-8. PubMed ID: 15130801
[TBL] [Abstract][Full Text] [Related]
10. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells.
Serwold T; Shastri N
J Immunol; 1999 Apr; 162(8):4712-9. PubMed ID: 10202012
[TBL] [Abstract][Full Text] [Related]
11. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules.
Niedermann G; Butz S; Ihlenfeldt HG; Grimm R; Lucchiari M; Hoschützky H; Jung G; Maier B; Eichmann K
Immunity; 1995 Mar; 2(3):289-99. PubMed ID: 7535183
[TBL] [Abstract][Full Text] [Related]
12. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
Torikai H; Akatsuka Y; Miyauchi H; Terakura S; Onizuka M; Tsujimura K; Miyamura K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Bone Marrow Transplant; 2007 Jul; 40(2):165-74. PubMed ID: 17530010
[TBL] [Abstract][Full Text] [Related]
13. The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303.
Torikai H; Akatsuka Y; Miyazaki M; Tsujimura A; Yatabe Y; Kawase T; Nakao Y; Tsujimura K; Motoyoshi K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
Br J Haematol; 2006 Aug; 134(4):406-16. PubMed ID: 16822283
[TBL] [Abstract][Full Text] [Related]
14. PAProC: a prediction algorithm for proteasomal cleavages available on the WWW.
Nussbaum AK; Kuttler C; Hadeler KP; Rammensee HG; Schild H
Immunogenetics; 2001 Mar; 53(2):87-94. PubMed ID: 11345595
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus mutation affects proteasomal epitope processing.
Seifert U; Liermann H; Racanelli V; Halenius A; Wiese M; Wedemeyer H; Ruppert T; Rispeter K; Henklein P; Sijts A; Hengel H; Kloetzel PM; Rehermann B
J Clin Invest; 2004 Jul; 114(2):250-9. PubMed ID: 15254592
[TBL] [Abstract][Full Text] [Related]
17. Two new proteases in the MHC class I processing pathway.
Stoltze L; Schirle M; Schwarz G; Schröter C; Thompson MW; Hersh LB; Kalbacher H; Stevanovic S; Rammensee HG; Schild H
Nat Immunol; 2000 Nov; 1(5):413-8. PubMed ID: 11062501
[TBL] [Abstract][Full Text] [Related]
18. Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.
Ito Y; Kondo E; Demachi-Okamura A; Akatsuka Y; Tsujimura K; Tanimoto M; Morishima Y; Takahashi T; Kuzushima K
J Virol; 2006 Jan; 80(2):883-90. PubMed ID: 16378990
[TBL] [Abstract][Full Text] [Related]
19. The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein.
Spierings E; Brickner AG; Caldwell JA; Zegveld S; Tatsis N; Blokland E; Pool J; Pierce RA; Mollah S; Shabanowitz J; Eisenlohr LC; van Veelen P; Ossendorp F; Hunt DF; Goulmy E; Engelhard VH
Blood; 2003 Jul; 102(2):621-9. PubMed ID: 12663445
[TBL] [Abstract][Full Text] [Related]
20. Insights from MHC-bound peptides.
Margalit H; Altuvia Y
Novartis Found Symp; 2003; 254():77-90; discussion 91-101, 216-22, 250-2. PubMed ID: 14712933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
